Taurolock

DEVICE4 trials

Sponsors

Aarhus University Hospital, Centre Hospitalier Universitaire de Nīmes, Hospices Civils de Lyon, Centre Hospitalier Régional Metz-Thionville

Conditions

BacteremiaCancerCatheter-Related InfectionsCatheter-related InfectionsInfectionNeoplasmsPeritonitisRenal Insufficiency

Phase 3

Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia

CompletedNCT00735813

Aarhus University HospitalBacteremia, Neoplasms

Start: 2008-04-30End: 2012-09-30Updated: 2012-09-05

Unknown Phase

Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency

CompletedNCT01101087

Centre Hospitalier Universitaire de NīmesCatheter-related Infections, Peritonitis, Renal Insufficiency

Start: 2010-07-31End: 2015-12-31Updated: 2015-12-18

Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition

Hospices Civils de LyonCancer, Infection

Start: 2015-01-31End: 2017-05-31Target: 70Updated: 2016-10-28

ATAPAC Study (TauroLock Activity in Adult Cancer Patients)

CompletedNCT02279121

Centre Hospitalier Régional Metz-ThionvilleCatheter-Related Infections

Start: 2014-11-01End: 2016-03-01Updated: 2026-06-24

Related Papers

Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.

2013-02-1541 citations